Uncover creative and innovative insights to control costs along the hazardous drug continuum Request More Information ChemoLock™ Needlefree Closed System Transfer Device (CSTD) Click-to-lock closed system transfer device ChemoClave™ Needlefree Closed System Transfer Device (CSTD) Familiar luer-based...
The NIOSH definitions are as follows: nClosed system drug-transfer device (CSTD): a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system. nnClosed system: a device that...
密闭式药液转移器-连接器Closed system drug-transfer device-Connector 管理类别 第二类 型号规格 Infusion Adapter (CI00) , L Connector (C90) , Connector Luer Lock(C45) , Connector Luer Lock(C35) 结构及组成 连接器C100 由密封膜、穿刺针、穿刺针保护盖和输液连接港组成。连接器C35 和C45 由密封膜、...
密闭式药液转移器-注射件 Closed system drug-transfer device-Injector 管理类别 第二类 型号规格 Injector Luer(N30C),Injector Luer Lock(N35),Injector Luer Lock(N35C),M50 结构及组成 产品由密封膜、密封圈、活塞、气缸、针管外套、安全筒、针管、帽子、鲁尔接头适配器外罩和锁定器组成。
ProSeal™ Closed System drug Transfer Device (CSTD)产品名称,K192075申请号,510k申请类型,Epic Medical Pte. Ltd.申请人,数据来源于药智数据美国上市器械数据库。
Understand the importance of closed system transfer devices. Prioritize drug safety. Call now for information. 516-684-8200
EQUASHIELD® is the most advanced Closed System Transfer Device (CSTD) available. It has been recognized as the fastest and most user-friendly system in numerous peer-reviewed studies. Mundus Mini HD, our automated compounding solution, seamlessly incorporates our CSTDs as an extra layer of prote...
which is a type of needleless closed system transfer device, for use during the large-scale COVID-19 vaccinations. The model had a drug delivery efficiency of 96.7% for 0.2 mL/shot injections and 97.8% drug transfer efficiency at 0.5 mL/shot. The proposed model could be used commercially, ...
which is a type of needleless closed system transfer device, for use during the large-scale COVID-19 vaccinations. The model had a drug delivery efficiency of 96.7% for 0.2 mL/shot injections and 97.8% drug transfer efficiency at 0.5 mL/shot. The proposed model could be used commercially, ...
Here we introduce a miniaturized bio-optoelectronic implant that avoids these limitations by using (1) an optical stimulation interface that exploits microscale inorganic light-emitting diodes to activate opsins; (2) a soft, high-precision biophysical sensor system that allows continuous measurements of ...